Gilead Sciences, Inc.
GLP-1R MODULATING COMPOUNDS

Last updated:

Abstract:

The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.

Status:
Application
Type:

Utility

Filling date:

18 Nov 2021

Issue date:

9 Jun 2022